Mark Fitzpatrick

2015 - Aegerion Pharmaceuticals

In 2015, Mark Fitzpatrick earned a total compensation of $1.2M as former Chief Financial Officer at Aegerion Pharmaceuticals, a 20% decrease compared to previous year.

Compensation breakdown

Option Awards$783,955
Salary$159,521
Stock Awards$260,000
Other$9,171
Total$1,212,646

Fitzpatrick received $784K in option awards, accounting for 65% of the total pay in 2015.

Fitzpatrick also received $159.5K in salary, $260K in stock awards and $9.2K in other compensation.

Rankings

In 2015, Mark Fitzpatrick's compensation ranked 7,007th out of 13,638 executives tracked by ExecPay. In other words, Fitzpatrick earned more than 48.6% of executives.

ClassificationRankingPercentile
All
7,007
out of 13,638
49th
Division
Manufacturing
2,648
out of 5,190
49th
Major group
Chemicals And Allied Products
953
out of 1,854
49th
Industry group
Drugs
766
out of 1,528
50th
Industry
Pharmaceutical Preparations
596
out of 1,182
50th
Source: SEC filing on April 29, 2016.

Fitzpatrick's colleagues

We found seven more compensation records of executives who worked with Mark Fitzpatrick at Aegerion Pharmaceuticals in 2015.

2015

Marc Beer

Aegerion Pharmaceuticals

Chief Executive Officer

2015

Gregory Perry

Aegerion Pharmaceuticals

Chief Financial & Administration Officer

2015

Mark Sumeray

Aegerion Pharmaceuticals

Chief Medical Officer

2015

Martha Carter

Aegerion Pharmaceuticals

Chief Regulatory Officer

2015

Mary Weger

Aegerion Pharmaceuticals

former Chief Performance Officer

2015

Sandford Smith

Aegerion Pharmaceuticals

Chief Executive Officer

2015

David Aubuchon

Aegerion Pharmaceuticals

Chief Financial Officer

In-depth

You may also like